Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study

Author(s): Siyamak Shahab, Masoome Sheikhi*

Journal Name: Current Molecular Medicine

Volume 21 , Issue 8 , 2021

Become EABM
Become Reviewer
Call for Editor


Triazavirin (2-methylsulfanyl-6-nitro[1,2,4]triazolo[5,1-c][1,2,4]triazin-7(4H)- one, TZV) is an antiviral drug synthesized. TZV is being investigated for potential applications against the Coronavirus 2019-nCoV. In order to find candidate drugs for 2019-nCoV, we have carried out a computational study to screen for effective available drug Triazavirin (C5H4N6O3S), which may work as an inhibitor for the Mpro of 2019- nCoV. In the present work, first time, the molecular structure of the title molecule has been investigated using Density Functional Theory (DFT/B3LYP/MidiX) in the gas phase. The molecular HOMO-LUMO, excitation energies and oscillator strengths of the investigated compound have also been calculated and presented. The interaction of TZV compound with the Coronavirus was performed by molecular docking studies. Therefore, TZV can be used for potential applications against the Coronavirus 2019- nCoV.

Keywords: Triazavirin, coronavirus, DFT, electronic properties, molecular docking.Triazavirin, coronavirus, DFT, electronic properties, molecular docking.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 20 May, 2020
Page: [645 - 654]
Pages: 10
DOI: 10.2174/1566524020666200521075848
Price: $95

Article Metrics

PDF: 294